Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 10:35PM GMT
Release Date Price: €53.26 (+3.06%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

So you're ready to get started? All right. Well, thanks, everyone, for joining us. My name is Matt Miksic. I am a medical device analyst here at Crédit Suisse.

Very pleased to have with us again this year the folks from Tandem Diabetes: Kim Blickenstaff, Executive Chairman; and Leigh Vosseller, Executive Vice President and CFO. So thank you both for coming again.

Questions & Answers

Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

I wanted to maybe take a minute -- a lot of great things to talk about, obviously, with Tandem and with diabetes care, in general. But maybe either -- your choice, rewinding to Friday, there was some news and noise -- (inaudible) news. I guess it was noise. And then there was also some key developments around the quarter which sort of, I think, are worth talking out in terms of the trend of growth, the dynamics of Control-IQ approval and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot